Advertisement

Index by author

November 01, 1988; Volume 247,Issue 2

A

  1. Abrahamsson, T

    1. Characterization of the inhibitory effect of some antidepressant drugs on the outward transport of norepinephrine in the ischemic myocardium.
      L Carlsson and T Abrahamsson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 715-720;

  2. Accaputo, J

    1. Combined hepatic arterial-portal venous and hepatic arterial-hepatic venous perfusions to probe the abundance of drug metabolizing activities: perihepatic venous O-deethylation activity for phenacetin and periportal sulfation activity for acetaminophen in the once-through rat liver preparation.
      K S Pang, W F Cherry, J Accaputo, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 690-700;

  3. Alden, B M

    1. Ontogeny of renal hemodynamic response to terbutaline and forskolin in sheep.
      K T Nakamura, B M Alden, G P Matherne, P A Jose and J E Robillard
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 453-459;

  4. Anderson, E G

    1. Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites.
      W Marszalec, R S Scroggs and E G Anderson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 399-404;

B

  1. Benjamin, D

    1. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal.
      H Lal, C M Harris, D Benjamin, A C Springfield, S Bhadra and M W Emmett-Oglesby
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 508-518;

  2. Berson, A

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  3. Bhadra, S

    1. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal.
      H Lal, C M Harris, D Benjamin, A C Springfield, S Bhadra and M W Emmett-Oglesby
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 508-518;

  4. Bhatnagar, R K

    1. Alterations in acetylcholine metabolism in rat striatal slices by a 4-methyl piperidine analog of hemicholinium-3.
      C E Tedford, J R Flynn, R K Bhatnagar, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 460-465;

  5. Bilous, M

    1. Altered hepatic calcium homeostasis in guinea pigs with halothane-induced hepatotoxicity.
      G C Farrell, J Mahoney, M Bilous and L Frost
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 751-756;

  6. Boast, C A

    1. Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist.
      C A Boast, G Pastor, S C Gerhardt, N R Hall and J M Liebman
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 556-561;

  7. Boise, L H

    1. Differential effects of coadministration of aminoacetonitrile on immunosuppression and hepatotoxicity produced by dimethylnitrosamine.
      H G Haggerty, L H Boise, S D Jordan and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 774-780;

  8. Bollinger, D W

    1. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
      J T Turner, D W Bollinger and M L Toews
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 417-423;

  9. Borchardt, R T

    1. Effect of ibopamine and the active metabolite epinine on the catecholamine content of rat hypothalamus and brainstem in vitro.
      G K Scriba, J A Hower, N Y Liang, P V Fennessey and R T Borchardt
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 609-616;

  10. Borison, H L

    1. Central respiratory inhibition by angiotensin II in anesthetized cats.
      H L Borison, J I Hubbard and L E McCarthy
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 781-790;

  11. Boulanger, C

    1. Endothelium-dependent effects of carteolol.
      P Janczewski, C Boulanger, A Iqbal and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 590-595;

  12. Boyea, S R

    1. Accumulation and clearance of morphine-3-beta-D-glucuronide in fetal lambs.
      G D Olsen, K M Sommer, P L Wheeler, S R Boyea, S P Michelson and D B Cheek
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 576-584;

  13. Brion, F

    1. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
      S De la Baume, F Brion, M Dam Trung Tuong and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 653-660;

  14. Bush, L R

    1. Effects of 3-methoxycyproheptadine in a canine model of coronary thrombosis.
      L R Bush and D C Remy
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 796-802;

  15. Bykov, V

    1. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
      R B Rothman, J B Long, V Bykov, A E Jacobson, K C Rice and J W Holaday
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 405-416;

C

  1. Cannon, J G

    1. Alterations in acetylcholine metabolism in rat striatal slices by a 4-methyl piperidine analog of hemicholinium-3.
      C E Tedford, J R Flynn, R K Bhatnagar, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 460-465;
    2. Stereoisomers of quaternary and tertiary 4-methyl piperidine analogs of hemicholinium-3.
      K Y Sheff, C E Tedford, J R Flynn, M A Yorek, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 640-644;

  2. Carlen, P L

    1. Hyperexcitability of hippocampal CA1 neurons in brain slices of rats chronically administered clonazepam.
      M F Davies, S E Sasaki and P L Carlen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 737-744;

  3. Carlsson, L

    1. Characterization of the inhibitory effect of some antidepressant drugs on the outward transport of norepinephrine in the ischemic myocardium.
      L Carlsson and T Abrahamsson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 715-720;

  4. Cheek, D B

    1. Accumulation and clearance of morphine-3-beta-D-glucuronide in fetal lambs.
      G D Olsen, K M Sommer, P L Wheeler, S R Boyea, S P Michelson and D B Cheek
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 576-584;

  5. Cherry, P D

    1. Antagonism of acetylcholine-mediated relaxation of rabbit pulmonary arteries by phorbol myristate acetate.
      P D Cherry and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 542-546;

  6. Cherry, W F

    1. Combined hepatic arterial-portal venous and hepatic arterial-hepatic venous perfusions to probe the abundance of drug metabolizing activities: perihepatic venous O-deethylation activity for phenacetin and periportal sulfation activity for acetaminophen in the once-through rat liver preparation.
      K S Pang, W F Cherry, J Accaputo, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 690-700;

  7. Choca, J I

    1. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study.
      J I Choca, R D Green and H K Proudfit
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 757-764;

  8. Chun, A L

    1. Effect of contractile activity on muscarinic receptor density and the response to muscarinic agonists.
      R M Levin, A L Chun, S Kitada, B B Garber and A J Wein
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 624-629;

  9. Cleary, J

    1. Effects of buprenorphine, methadone and naloxone on acquisition of behavioral chains.
      J Cleary, B Ho, M Nader and T Thompson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 569-575;

  10. Clerici, C

    1. Mechanism of histamine-induced epinephrine release in guinea pig.
      I Macquin-Mavier, C Clerici, M L Franco-Montoya and A Harf
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 706-709;

  11. Cohen, G

    1. Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione.
      M B Spina and G Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 502-507;

  12. Cornwell, T L

    1. Regulation of phosphorylase A formation and calcium content in aortic smooth muscle and smooth muscle cells: effects of atrial natriuretic peptide II.
      T L Cornwell and T M Lincoln
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 524-530;

  13. Corpuz, R P

    1. A radioimmunoassay for pyridostigmine.
      H G Meyer, B J Lukey, R T Gepp, R P Corpuz and C N Lieske
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 432-438;

  14. Crooke, S T

    1. Leukotriene D4 receptor-mediated phosphoinositol hydrolysis and calcium mobilization in rat basophilic leukemic cells.
      S Mong, H L Wu, A Wong, H M Sarau and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 803-813;

  15. Cubeddu, L X

    1. Monoamine release by compound 48/80 from nonmast cell compartments in mouse brain slices.
      T W Lovenberg and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 562-568;

D

  1. Dam Trung Tuong, M

    1. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
      S De la Baume, F Brion, M Dam Trung Tuong and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 653-660;

  2. Davies, M F

    1. Hyperexcitability of hippocampal CA1 neurons in brain slices of rats chronically administered clonazepam.
      M F Davies, S E Sasaki and P L Carlen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 737-744;

  3. DeCarli, L M

    1. Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system.
      C S Lieber, J M Lasker, L M DeCarli, J Saeli and T Wojtowicz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 791-795;

  4. de Chaffoy de Courcelles, D

    1. Biochemical profile of risperidone, a new antipsychotic.
      J E Leysen, W Gommeren, A Eens, D de Chaffoy de Courcelles, J C Stoof and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 661-670;

  5. Degott, C

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  6. De la Baume, S

    1. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
      S De la Baume, F Brion, M Dam Trung Tuong and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 653-660;

  7. Dretchen, K L

    1. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
      R A Gillis, D P Walton, J A Quest, I J Namath, P Hamosh and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 765-773;

E

  1. Eens, A

    1. Biochemical profile of risperidone, a new antipsychotic.
      J E Leysen, W Gommeren, A Eens, D de Chaffoy de Courcelles, J C Stoof and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 661-670;

  2. Eguchi, N

    1. Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats.
      N Eguchi, H Hayashi, Y Urade, S Ito and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 671-679;

  3. Ehlert, F J

    1. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
      F J Ehlert
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 596-602;

  4. Emmett-Oglesby, M W

    1. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal.
      H Lal, C M Harris, D Benjamin, A C Springfield, S Bhadra and M W Emmett-Oglesby
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 508-518;

F

  1. Farrell, G C

    1. Altered hepatic calcium homeostasis in guinea pigs with halothane-induced hepatotoxicity.
      G C Farrell, J Mahoney, M Bilous and L Frost
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 751-756;

  2. Fennessey, P V

    1. Effect of ibopamine and the active metabolite epinine on the catecholamine content of rat hypothalamus and brainstem in vitro.
      G K Scriba, J A Hower, N Y Liang, P V Fennessey and R T Borchardt
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 609-616;

  3. Flynn, J R

    1. Alterations in acetylcholine metabolism in rat striatal slices by a 4-methyl piperidine analog of hemicholinium-3.
      C E Tedford, J R Flynn, R K Bhatnagar, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 460-465;
    2. Stereoisomers of quaternary and tertiary 4-methyl piperidine analogs of hemicholinium-3.
      K Y Sheff, C E Tedford, J R Flynn, M A Yorek, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 640-644;

  4. Fondacaro, J D

    1. Selective alpha-2 adrenoceptor agonists alter fluid and electrolyte transport in mammalian small intestine.
      J D Fondacaro, D Kolpak and G P McCafferty
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 481-486;

  5. Franco-Montoya, M L

    1. Mechanism of histamine-induced epinephrine release in guinea pig.
      I Macquin-Mavier, C Clerici, M L Franco-Montoya and A Harf
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 706-709;

  6. Freneaux, E

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  7. Frost, L

    1. Altered hepatic calcium homeostasis in guinea pigs with halothane-induced hepatotoxicity.
      G C Farrell, J Mahoney, M Bilous and L Frost
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 751-756;

  8. Fujimoto, J M

    1. Morphine antinociception in different strains of mice: relationship of supraspinal-spinal multiplicative interaction to tolerance.
      S C Roerig and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 603-608;

  9. Fujino, K

    1. Differential effects of d- and l-pimobendan on cardiac myofilament calcium sensitivity.
      K Fujino, N Sperelakis and R J Solaro
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 519-523;

  10. Fujiwara, M

    1. An endothelium-dependent contraction induced by A-23187, a Ca++ ionophore in canine basilar artery.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 701-705;

  11. Fuller, R W

    1. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
      R W Fuller, S K Hemrick-Luecke and K W Perry
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 531-535;

  12. Fulmor, I E

    1. Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatment.
      G J Grover and I E Fulmor
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 445-452;

G

  1. Gandhi, V C

    1. Identification and characterization of [3H]nitrendipine binding sites in rat spinal cord.
      V C Gandhi and D J Jones
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 473-480;

  2. Garber, B B

    1. Effect of contractile activity on muscarinic receptor density and the response to muscarinic agonists.
      R M Levin, A L Chun, S Kitada, B B Garber and A J Wein
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 624-629;

  3. Garg, L C

    1. Effects of osmolality on phosphoinositide hydrolysis in renal medulla.
      L C Garg, E Kapturczak and S McArdle
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 495-501;

  4. Geneve, J

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  5. Gepp, R T

    1. A radioimmunoassay for pyridostigmine.
      H G Meyer, B J Lukey, R T Gepp, R P Corpuz and C N Lieske
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 432-438;

  6. Gerhardt, S C

    1. Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist.
      C A Boast, G Pastor, S C Gerhardt, N R Hall and J M Liebman
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 556-561;

  7. Geyer, M A

    1. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.
      L H Gold, G F Koob and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 547-555;

  8. Giardi, A

    1. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
      G Maura, A Giardi and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 680-684;

  9. Gillis, C N

    1. Antagonism of acetylcholine-mediated relaxation of rabbit pulmonary arteries by phorbol myristate acetate.
      P D Cherry and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 542-546;

  10. Gillis, R A

    1. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
      R A Gillis, D P Walton, J A Quest, I J Namath, P Hamosh and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 765-773;

  11. Gold, L H

    1. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.
      L H Gold, G F Koob and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 547-555;

  12. Gommeren, W

    1. Biochemical profile of risperidone, a new antipsychotic.
      J E Leysen, W Gommeren, A Eens, D de Chaffoy de Courcelles, J C Stoof and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 661-670;

  13. Goresky, C A

    1. Combined hepatic arterial-portal venous and hepatic arterial-hepatic venous perfusions to probe the abundance of drug metabolizing activities: perihepatic venous O-deethylation activity for phenacetin and periportal sulfation activity for acetaminophen in the once-through rat liver preparation.
      K S Pang, W F Cherry, J Accaputo, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 690-700;

  14. Green, R D

    1. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study.
      J I Choca, R D Green and H K Proudfit
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 757-764;

  15. Gross, S S

    1. Positive inotropic effect of histamine on guinea pig left atrium: H1-receptor-induced stimulation of phosphoinositide turnover.
      I Sakuma, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 466-472;

  16. Grover, G J

    1. Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatment.
      G J Grover and I E Fulmor
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 445-452;

  17. Grunewald, G L

    1. Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs.
      S M Knepper, G L Grunewald and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 487-494;

H

  1. Haggerty, H G

    1. Differential effects of coadministration of aminoacetonitrile on immunosuppression and hepatotoxicity produced by dimethylnitrosamine.
      H G Haggerty, L H Boise, S D Jordan and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 774-780;

  2. Hall, N R

    1. Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist.
      C A Boast, G Pastor, S C Gerhardt, N R Hall and J M Liebman
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 556-561;

  3. Hamosh, P

    1. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
      R A Gillis, D P Walton, J A Quest, I J Namath, P Hamosh and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 765-773;

  4. Handley, D A

    1. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
      D A Handley, R G Van Valen, M K Melden, W J Houlihan and R N Saunders
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 617-623;

  5. Harf, A

    1. Mechanism of histamine-induced epinephrine release in guinea pig.
      I Macquin-Mavier, C Clerici, M L Franco-Montoya and A Harf
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 706-709;

  6. Harris, C M

    1. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal.
      H Lal, C M Harris, D Benjamin, A C Springfield, S Bhadra and M W Emmett-Oglesby
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 508-518;

  7. Hayaishi, O

    1. Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats.
      N Eguchi, H Hayashi, Y Urade, S Ito and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 671-679;

  8. Hayashi, H

    1. Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats.
      N Eguchi, H Hayashi, Y Urade, S Ito and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 671-679;

  9. Hemrick-Luecke, S K

    1. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
      R W Fuller, S K Hemrick-Luecke and K W Perry
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 531-535;

  10. Herz, A

    1. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
      M J Millan, B J Morris and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 721-728;
    2. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
      B J Morris, M J Millan and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 729-736;

  11. Hieble, J P

    1. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
      J P Hieble, A C Sulpizio, A J Nichols, R N Willette and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 645-652;

  12. Ho, B

    1. Effects of buprenorphine, methadone and naloxone on acquisition of behavioral chains.
      J Cleary, B Ho, M Nader and T Thompson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 569-575;

  13. Hoffman, P L

    1. Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressin.
      G Szabó, B Tabakoff and P L Hoffman
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 536-541;

  14. Holaday, J W

    1. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
      R B Rothman, J B Long, V Bykov, A E Jacobson, K C Rice and J W Holaday
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 405-416;

  15. Holsapple, M P

    1. Differential effects of coadministration of aminoacetonitrile on immunosuppression and hepatotoxicity produced by dimethylnitrosamine.
      H G Haggerty, L H Boise, S D Jordan and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 774-780;

  16. Houlihan, W J

    1. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
      D A Handley, R G Van Valen, M K Melden, W J Houlihan and R N Saunders
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 617-623;

  17. Hower, J A

    1. Effect of ibopamine and the active metabolite epinine on the catecholamine content of rat hypothalamus and brainstem in vitro.
      G K Scriba, J A Hower, N Y Liang, P V Fennessey and R T Borchardt
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 609-616;

  18. Hubbard, J I

    1. Central respiratory inhibition by angiotensin II in anesthetized cats.
      H L Borison, J I Hubbard and L E McCarthy
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 781-790;

I

  1. Iqbal, A

    1. Endothelium-dependent effects of carteolol.
      P Janczewski, C Boulanger, A Iqbal and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 590-595;

  2. Ito, S

    1. Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats.
      N Eguchi, H Hayashi, Y Urade, S Ito and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 671-679;

J

  1. Jacobson, A E

    1. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
      R B Rothman, J B Long, V Bykov, A E Jacobson, K C Rice and J W Holaday
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 405-416;

  2. Janczewski, P

    1. Endothelium-dependent effects of carteolol.
      P Janczewski, C Boulanger, A Iqbal and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 590-595;

  3. Janssen, P A

    1. Biochemical profile of risperidone, a new antipsychotic.
      J E Leysen, W Gommeren, A Eens, D de Chaffoy de Courcelles, J C Stoof and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 661-670;

  4. Jones, D J

    1. Identification and characterization of [3H]nitrendipine binding sites in rat spinal cord.
      V C Gandhi and D J Jones
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 473-480;

  5. Jordan, S D

    1. Differential effects of coadministration of aminoacetonitrile on immunosuppression and hepatotoxicity produced by dimethylnitrosamine.
      H G Haggerty, L H Boise, S D Jordan and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 774-780;

  6. Jose, P A

    1. Ontogeny of renal hemodynamic response to terbutaline and forskolin in sheep.
      K T Nakamura, B M Alden, G P Matherne, P A Jose and J E Robillard
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 453-459;

K

  1. Kapturczak, E

    1. Effects of osmolality on phosphoinositide hydrolysis in renal medulla.
      L C Garg, E Kapturczak and S McArdle
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 495-501;

  2. Kharasch, E D

    1. Nitrofurantoin-stimulated proteolysis in human erythrocytes: a novel index of toxic insult by nitroaromatics.
      R F Novak, E D Kharasch and N K Wendel
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 439-444;

  3. Kitada, S

    1. Effect of contractile activity on muscarinic receptor density and the response to muscarinic agonists.
      R M Levin, A L Chun, S Kitada, B B Garber and A J Wein
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 624-629;

  4. Klein, M

    1. High affinity dextromethorphan binding sites in guinea pig brain: further characterization and allosteric interactions.
      J M Musacchio, M Klein and L J Santiago
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 424-431;

  5. Knepper, S M

    1. Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs.
      S M Knepper, G L Grunewald and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 487-494;

  6. Kolpak, D

    1. Selective alpha-2 adrenoceptor agonists alter fluid and electrolyte transport in mammalian small intestine.
      J D Fondacaro, D Kolpak and G P McCafferty
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 481-486;

  7. Koob, G F

    1. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.
      L H Gold, G F Koob and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 547-555;

  8. Kukongviriyapan, V

    1. Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes.
      V Kukongviriyapan and N H Stacey
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 685-689;

  9. Kurahashi, K

    1. An endothelium-dependent contraction induced by A-23187, a Ca++ ionophore in canine basilar artery.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 701-705;

L

  1. Labbe, G

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  2. Lal, H

    1. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal.
      H Lal, C M Harris, D Benjamin, A C Springfield, S Bhadra and M W Emmett-Oglesby
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 508-518;

  3. Larrey, D

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  4. Lasker, J M

    1. Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system.
      C S Lieber, J M Lasker, L M DeCarli, J Saeli and T Wojtowicz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 791-795;

  5. Le Dinh, T

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  6. Letteron, P

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  7. Levi, R

    1. Positive inotropic effect of histamine on guinea pig left atrium: H1-receptor-induced stimulation of phosphoinositide turnover.
      I Sakuma, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 466-472;

  8. Levin, R M

    1. Effect of contractile activity on muscarinic receptor density and the response to muscarinic agonists.
      R M Levin, A L Chun, S Kitada, B B Garber and A J Wein
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 624-629;

  9. Leysen, J E

    1. Biochemical profile of risperidone, a new antipsychotic.
      J E Leysen, W Gommeren, A Eens, D de Chaffoy de Courcelles, J C Stoof and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 661-670;

  10. Liang, N Y

    1. Effect of ibopamine and the active metabolite epinine on the catecholamine content of rat hypothalamus and brainstem in vitro.
      G K Scriba, J A Hower, N Y Liang, P V Fennessey and R T Borchardt
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 609-616;

  11. Lieber, C S

    1. Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system.
      C S Lieber, J M Lasker, L M DeCarli, J Saeli and T Wojtowicz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 791-795;

  12. Liebman, J M

    1. Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist.
      C A Boast, G Pastor, S C Gerhardt, N R Hall and J M Liebman
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 556-561;

  13. Lieske, C N

    1. A radioimmunoassay for pyridostigmine.
      H G Meyer, B J Lukey, R T Gepp, R P Corpuz and C N Lieske
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 432-438;

  14. Lincoln, T M

    1. Regulation of phosphorylase A formation and calcium content in aortic smooth muscle and smooth muscle cells: effects of atrial natriuretic peptide II.
      T L Cornwell and T M Lincoln
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 524-530;

  15. Long, J B

    1. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
      R B Rothman, J B Long, V Bykov, A E Jacobson, K C Rice and J W Holaday
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 405-416;

  16. Long, J P

    1. Alterations in acetylcholine metabolism in rat striatal slices by a 4-methyl piperidine analog of hemicholinium-3.
      C E Tedford, J R Flynn, R K Bhatnagar, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 460-465;
    2. Stereoisomers of quaternary and tertiary 4-methyl piperidine analogs of hemicholinium-3.
      K Y Sheff, C E Tedford, J R Flynn, M A Yorek, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 640-644;

  17. Lovenberg, T W

    1. Monoamine release by compound 48/80 from nonmast cell compartments in mouse brain slices.
      T W Lovenberg and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 562-568;

  18. Lukey, B J

    1. A radioimmunoassay for pyridostigmine.
      H G Meyer, B J Lukey, R T Gepp, R P Corpuz and C N Lieske
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 432-438;

  19. Lüllmann, H

    1. Release of N-[3H]methylscopolamine from isolated guinea pig atria is controlled by diffusion and rebinding.
      H Lüllmann, K Mohr and J Pfeffer
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 710-714;

M

  1. Macquin-Mavier, I

    1. Mechanism of histamine-induced epinephrine release in guinea pig.
      I Macquin-Mavier, C Clerici, M L Franco-Montoya and A Harf
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 706-709;

  2. Mahoney, J

    1. Altered hepatic calcium homeostasis in guinea pigs with halothane-induced hepatotoxicity.
      G C Farrell, J Mahoney, M Bilous and L Frost
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 751-756;

  3. Manabe, K

    1. An endothelium-dependent contraction induced by A-23187, a Ca++ ionophore in canine basilar artery.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 701-705;

  4. Marszalec, W

    1. Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites.
      W Marszalec, R S Scroggs and E G Anderson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 399-404;

  5. Matherne, G P

    1. Ontogeny of renal hemodynamic response to terbutaline and forskolin in sheep.
      K T Nakamura, B M Alden, G P Matherne, P A Jose and J E Robillard
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 453-459;

  6. Maura, G

    1. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
      G Maura, A Giardi and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 680-684;

  7. McArdle, S

    1. Effects of osmolality on phosphoinositide hydrolysis in renal medulla.
      L C Garg, E Kapturczak and S McArdle
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 495-501;

  8. McCafferty, G P

    1. Selective alpha-2 adrenoceptor agonists alter fluid and electrolyte transport in mammalian small intestine.
      J D Fondacaro, D Kolpak and G P McCafferty
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 481-486;

  9. McCarthy, L E

    1. Central respiratory inhibition by angiotensin II in anesthetized cats.
      H L Borison, J I Hubbard and L E McCarthy
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 781-790;

  10. Melden, M K

    1. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
      D A Handley, R G Van Valen, M K Melden, W J Houlihan and R N Saunders
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 617-623;

  11. Meyer, H G

    1. A radioimmunoassay for pyridostigmine.
      H G Meyer, B J Lukey, R T Gepp, R P Corpuz and C N Lieske
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 432-438;

  12. Michelson, S P

    1. Accumulation and clearance of morphine-3-beta-D-glucuronide in fetal lambs.
      G D Olsen, K M Sommer, P L Wheeler, S R Boyea, S P Michelson and D B Cheek
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 576-584;

  13. Millan, M J

    1. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
      M J Millan, B J Morris and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 721-728;
    2. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
      B J Morris, M J Millan and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 729-736;

  14. Mohr, K

    1. Release of N-[3H]methylscopolamine from isolated guinea pig atria is controlled by diffusion and rebinding.
      H Lüllmann, K Mohr and J Pfeffer
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 710-714;

  15. Mong, S

    1. Leukotriene D4 receptor-mediated phosphoinositol hydrolysis and calcium mobilization in rat basophilic leukemic cells.
      S Mong, H L Wu, A Wong, H M Sarau and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 803-813;

  16. Morris, B J

    1. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
      M J Millan, B J Morris and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 721-728;
    2. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
      B J Morris, M J Millan and A Herz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 729-736;

  17. Musacchio, J M

    1. High affinity dextromethorphan binding sites in guinea pig brain: further characterization and allosteric interactions.
      J M Musacchio, M Klein and L J Santiago
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 424-431;

N

  1. Nader, M

    1. Effects of buprenorphine, methadone and naloxone on acquisition of behavioral chains.
      J Cleary, B Ho, M Nader and T Thompson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 569-575;

  2. Nakamura, K T

    1. Ontogeny of renal hemodynamic response to terbutaline and forskolin in sheep.
      K T Nakamura, B M Alden, G P Matherne, P A Jose and J E Robillard
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 453-459;

  3. Namath, I J

    1. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
      R A Gillis, D P Walton, J A Quest, I J Namath, P Hamosh and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 765-773;

  4. Nichols, A J

    1. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
      J P Hieble, A C Sulpizio, A J Nichols, R N Willette and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 645-652;

  5. Novak, R F

    1. Nitrofurantoin-stimulated proteolysis in human erythrocytes: a novel index of toxic insult by nitroaromatics.
      R F Novak, E D Kharasch and N K Wendel
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 439-444;

O

  1. Olsen, G D

    1. Accumulation and clearance of morphine-3-beta-D-glucuronide in fetal lambs.
      G D Olsen, K M Sommer, P L Wheeler, S R Boyea, S P Michelson and D B Cheek
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 576-584;

P

  1. Pang, K S

    1. Combined hepatic arterial-portal venous and hepatic arterial-hepatic venous perfusions to probe the abundance of drug metabolizing activities: perihepatic venous O-deethylation activity for phenacetin and periportal sulfation activity for acetaminophen in the once-through rat liver preparation.
      K S Pang, W F Cherry, J Accaputo, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 690-700;

  2. Pastor, G

    1. Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist.
      C A Boast, G Pastor, S C Gerhardt, N R Hall and J M Liebman
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 556-561;

  3. Perry, K W

    1. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
      R W Fuller, S K Hemrick-Luecke and K W Perry
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 531-535;

  4. Pessayre, D

    1. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
      T Le Dinh, E Freneaux, G Labbe, P Letteron, C Degott, J Geneve, A Berson, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 745-750;

  5. Pfeffer, J

    1. Release of N-[3H]methylscopolamine from isolated guinea pig atria is controlled by diffusion and rebinding.
      H Lüllmann, K Mohr and J Pfeffer
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 710-714;

  6. Proudfit, H K

    1. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study.
      J I Choca, R D Green and H K Proudfit
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 757-764;

Q

  1. Quest, J A

    1. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
      R A Gillis, D P Walton, J A Quest, I J Namath, P Hamosh and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 765-773;

R

  1. Raiteri, M

    1. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
      G Maura, A Giardi and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 680-684;

  2. Remy, D C

    1. Effects of 3-methoxycyproheptadine in a canine model of coronary thrombosis.
      L R Bush and D C Remy
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 796-802;

  3. Rice, K C

    1. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
      R B Rothman, J B Long, V Bykov, A E Jacobson, K C Rice and J W Holaday
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 405-416;

  4. Roberts, L A

    1. The positive chronotropic effect of acetylcholine has muscarinic and nicotinic components in the neonatal rat heart.
      L S Sun, L A Roberts, M R Rosen and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 585-589;

  5. Robillard, J E

    1. Ontogeny of renal hemodynamic response to terbutaline and forskolin in sheep.
      K T Nakamura, B M Alden, G P Matherne, P A Jose and J E Robillard
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 453-459;

  6. Robinson, R B

    1. The positive chronotropic effect of acetylcholine has muscarinic and nicotinic components in the neonatal rat heart.
      L S Sun, L A Roberts, M R Rosen and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 585-589;

  7. Roerig, S C

    1. Morphine antinociception in different strains of mice: relationship of supraspinal-spinal multiplicative interaction to tolerance.
      S C Roerig and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 603-608;

  8. Rosen, M R

    1. The positive chronotropic effect of acetylcholine has muscarinic and nicotinic components in the neonatal rat heart.
      L S Sun, L A Roberts, M R Rosen and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 585-589;

  9. Rothman, R B

    1. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
      R B Rothman, J B Long, V Bykov, A E Jacobson, K C Rice and J W Holaday
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 405-416;

  10. Ruffolo, R R

    1. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
      J P Hieble, A C Sulpizio, A J Nichols, R N Willette and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 645-652;

  11. Rutledge, C O

    1. Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs.
      S M Knepper, G L Grunewald and C O Rutledge
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 487-494;

S

  1. Saeli, J

    1. Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system.
      C S Lieber, J M Lasker, L M DeCarli, J Saeli and T Wojtowicz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 791-795;

  2. Sakuma, I

    1. Positive inotropic effect of histamine on guinea pig left atrium: H1-receptor-induced stimulation of phosphoinositide turnover.
      I Sakuma, S S Gross and R Levi
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 466-472;

  3. Santiago, L J

    1. High affinity dextromethorphan binding sites in guinea pig brain: further characterization and allosteric interactions.
      J M Musacchio, M Klein and L J Santiago
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 424-431;

  4. Sarau, H M

    1. Leukotriene D4 receptor-mediated phosphoinositol hydrolysis and calcium mobilization in rat basophilic leukemic cells.
      S Mong, H L Wu, A Wong, H M Sarau and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 803-813;

  5. Sasaki, S E

    1. Hyperexcitability of hippocampal CA1 neurons in brain slices of rats chronically administered clonazepam.
      M F Davies, S E Sasaki and P L Carlen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 737-744;

  6. Saunders, R N

    1. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
      D A Handley, R G Van Valen, M K Melden, W J Houlihan and R N Saunders
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 617-623;

  7. Schwab, A J

    1. Combined hepatic arterial-portal venous and hepatic arterial-hepatic venous perfusions to probe the abundance of drug metabolizing activities: perihepatic venous O-deethylation activity for phenacetin and periportal sulfation activity for acetaminophen in the once-through rat liver preparation.
      K S Pang, W F Cherry, J Accaputo, A J Schwab and C A Goresky
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 690-700;

  8. Schwartz, J C

    1. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
      S De la Baume, F Brion, M Dam Trung Tuong and J C Schwartz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 653-660;

  9. Scriba, G K

    1. Effect of ibopamine and the active metabolite epinine on the catecholamine content of rat hypothalamus and brainstem in vitro.
      G K Scriba, J A Hower, N Y Liang, P V Fennessey and R T Borchardt
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 609-616;

  10. Scroggs, R S

    1. Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites.
      W Marszalec, R S Scroggs and E G Anderson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 399-404;

  11. Sheff, K Y

    1. Stereoisomers of quaternary and tertiary 4-methyl piperidine analogs of hemicholinium-3.
      K Y Sheff, C E Tedford, J R Flynn, M A Yorek, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 640-644;

  12. Shirahase, H

    1. An endothelium-dependent contraction induced by A-23187, a Ca++ ionophore in canine basilar artery.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 701-705;

  13. Solaro, R J

    1. Differential effects of d- and l-pimobendan on cardiac myofilament calcium sensitivity.
      K Fujino, N Sperelakis and R J Solaro
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 519-523;

  14. Sommer, K M

    1. Accumulation and clearance of morphine-3-beta-D-glucuronide in fetal lambs.
      G D Olsen, K M Sommer, P L Wheeler, S R Boyea, S P Michelson and D B Cheek
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 576-584;

  15. Sperelakis, N

    1. Differential effects of d- and l-pimobendan on cardiac myofilament calcium sensitivity.
      K Fujino, N Sperelakis and R J Solaro
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 519-523;

  16. Spina, M B

    1. Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione.
      M B Spina and G Cohen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 502-507;

  17. Springfield, A C

    1. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal.
      H Lal, C M Harris, D Benjamin, A C Springfield, S Bhadra and M W Emmett-Oglesby
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 508-518;

  18. Stacey, N H

    1. Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes.
      V Kukongviriyapan and N H Stacey
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 685-689;

  19. Stoof, J C

    1. Biochemical profile of risperidone, a new antipsychotic.
      J E Leysen, W Gommeren, A Eens, D de Chaffoy de Courcelles, J C Stoof and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 661-670;

  20. Sulpizio, A C

    1. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
      J P Hieble, A C Sulpizio, A J Nichols, R N Willette and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 645-652;

  21. Sun, L S

    1. The positive chronotropic effect of acetylcholine has muscarinic and nicotinic components in the neonatal rat heart.
      L S Sun, L A Roberts, M R Rosen and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 585-589;

  22. Szabó, G

    1. Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressin.
      G Szabó, B Tabakoff and P L Hoffman
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 536-541;

T

  1. Tabakoff, B

    1. Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressin.
      G Szabó, B Tabakoff and P L Hoffman
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 536-541;

  2. Tedford, C E

    1. Alterations in acetylcholine metabolism in rat striatal slices by a 4-methyl piperidine analog of hemicholinium-3.
      C E Tedford, J R Flynn, R K Bhatnagar, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 460-465;
    2. Stereoisomers of quaternary and tertiary 4-methyl piperidine analogs of hemicholinium-3.
      K Y Sheff, C E Tedford, J R Flynn, M A Yorek, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 640-644;

  3. Thompson, T

    1. Effects of buprenorphine, methadone and naloxone on acquisition of behavioral chains.
      J Cleary, B Ho, M Nader and T Thompson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 569-575;

  4. Thomsen, R H

    1. Neuromuscular transmission changes associated with tolerance development after chronic exposure to diisopropylfluorophosphate.
      R H Thomsen and D F Wilson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 635-639;

  5. Toews, M L

    1. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
      J T Turner, D W Bollinger and M L Toews
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 417-423;

  6. Turner, J T

    1. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
      J T Turner, D W Bollinger and M L Toews
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 417-423;

U

  1. Urade, Y

    1. Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats.
      N Eguchi, H Hayashi, Y Urade, S Ito and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 671-679;

  2. Usui, H

    1. An endothelium-dependent contraction induced by A-23187, a Ca++ ionophore in canine basilar artery.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 701-705;

V

  1. Vanhoutte, P M

    1. Endothelium-dependent effects of carteolol.
      P Janczewski, C Boulanger, A Iqbal and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 590-595;

  2. Van Valen, R G

    1. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
      D A Handley, R G Van Valen, M K Melden, W J Houlihan and R N Saunders
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 617-623;

W

  1. Walton, D P

    1. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
      R A Gillis, D P Walton, J A Quest, I J Namath, P Hamosh and K L Dretchen
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 765-773;

  2. Wein, A J

    1. Effect of contractile activity on muscarinic receptor density and the response to muscarinic agonists.
      R M Levin, A L Chun, S Kitada, B B Garber and A J Wein
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 624-629;

  3. Weiss, R M

    1. Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments.
      R M Weiss and M A Wheeler
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 630-634;

  4. Wendel, N K

    1. Nitrofurantoin-stimulated proteolysis in human erythrocytes: a novel index of toxic insult by nitroaromatics.
      R F Novak, E D Kharasch and N K Wendel
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 439-444;

  5. Wheeler, M A

    1. Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments.
      R M Weiss and M A Wheeler
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 630-634;

  6. Wheeler, P L

    1. Accumulation and clearance of morphine-3-beta-D-glucuronide in fetal lambs.
      G D Olsen, K M Sommer, P L Wheeler, S R Boyea, S P Michelson and D B Cheek
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 576-584;

  7. Willette, R N

    1. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
      J P Hieble, A C Sulpizio, A J Nichols, R N Willette and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 645-652;

  8. Wilson, D F

    1. Neuromuscular transmission changes associated with tolerance development after chronic exposure to diisopropylfluorophosphate.
      R H Thomsen and D F Wilson
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 635-639;

  9. Wojtowicz, T

    1. Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system.
      C S Lieber, J M Lasker, L M DeCarli, J Saeli and T Wojtowicz
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 791-795;

  10. Wong, A

    1. Leukotriene D4 receptor-mediated phosphoinositol hydrolysis and calcium mobilization in rat basophilic leukemic cells.
      S Mong, H L Wu, A Wong, H M Sarau and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 803-813;

  11. Wu, H L

    1. Leukotriene D4 receptor-mediated phosphoinositol hydrolysis and calcium mobilization in rat basophilic leukemic cells.
      S Mong, H L Wu, A Wong, H M Sarau and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 803-813;

Y

  1. Yorek, M A

    1. Stereoisomers of quaternary and tertiary 4-methyl piperidine analogs of hemicholinium-3.
      K Y Sheff, C E Tedford, J R Flynn, M A Yorek, J G Cannon and J P Long
      Journal of Pharmacology and Experimental Therapeutics November 1988, 247 (2) 640-644;
Back to top

In this issue